Workflow
大北农(002385) - 2021 Q1 - 季度财报
DBN GroupDBN Group(SZ:002385)2021-04-26 16:00

Financial Performance - The company's revenue for Q1 2021 was ¥7,401,924,717.39, representing an increase of 81.37% compared to ¥4,081,196,693.95 in the same period last year[3]. - Net profit attributable to shareholders decreased by 16.01% to ¥390,933,756.67 from ¥465,462,716.98 year-on-year[3]. - Basic and diluted earnings per share both decreased by 9.09% to ¥0.10 from ¥0.11[3]. - Operating revenue for Q1 2021 increased by 3,320.73 million yuan, a growth of 81.37%, driven by higher sales of feed and live pigs[11]. - Operating profit for Q1 2021 was CNY 537,673,174.92, a decrease from CNY 626,595,891.77 in Q1 2020, showing a decline of about 14%[34]. - The total comprehensive income attributable to the parent company was CNY 391,097,527.94, compared to CNY 465,554,490.01 in Q1 2020, reflecting a decline of approximately 16%[35]. - The company reported a decrease in investment income by 86.04 million yuan, a decline of 48.48%, due to fewer equity transfer gains compared to the previous year[12]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥396,086,296.69, a decline of 427.78% compared to -¥75,046,967.14 in the previous year[3]. - Cash received from sales of goods and services increased by 3,186.46 million yuan, a growth of 81.14%, due to higher sales collections[13]. - Cash inflows from operating activities amounted to CNY 7.31 billion, up from CNY 4.06 billion year-on-year, indicating a growth of approximately 80.5%[39]. - The net cash flow from financing activities was CNY 552.62 million, down from CNY 943.29 million year-on-year, indicating a decrease of approximately 41.3%[41]. - The company's cash and cash equivalents decreased to CNY 1,375,888,550.91 from CNY 1,502,994,885.52, a decline of about 8.5%[29]. Assets and Liabilities - Total assets at the end of the reporting period were ¥25,578,696,514.55, an increase of 6.39% from ¥24,041,748,998.06 at the end of the previous year[3]. - The total liabilities increased to CNY 12,172,358,295.71 from CNY 11,004,905,744.58, reflecting a growth of about 10.6% year-over-year[28]. - The company's current assets totaled CNY 9.98 billion as of March 31, 2021, compared to CNY 9.57 billion at the end of 2020, indicating an increase of about 4.41%[25]. - The total liabilities increased by CNY 567,430,979.62 to CNY 11,572,336,724.20 as of January 1, 2021[49]. - The company's total liabilities and equity amounted to CNY 24,562,223,467.86 as of January 1, 2021[49]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 297,591[6]. - The largest shareholder, Shao Genhuo, holds 27.91% of the shares, totaling 1,171,094,399 shares[6]. - Net assets attributable to shareholders increased by 3.18% to ¥11,366,187,603.26 from ¥11,015,444,461.02[3]. Research and Development - R&D expenses for Q1 2021 increased by 48.39 million yuan, a growth of 65.73%, reflecting the company's increased investment in R&D personnel and projects[12]. - The company is actively engaged in research and development of new technologies and products to enhance its competitive positioning in the biotechnology sector[23]. Investment Activities - Trading financial assets increased by 99.77 million yuan, a growth of 5,370.10% compared to the beginning of the year, mainly due to the company's investment in financial products with temporarily idle funds[10]. - The company reported a total of 2,551.2 million in derivative investments, with a net asset ratio of 0.18% and a loss of 371.77 million during the reporting period[17]. - The company engaged in futures contracts for corn and soybean meal, with transactions occurring from January 1, 2021, to March 31, 2021[17]. Regulatory and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[21]. - There were no violations of external guarantees during the reporting period[21]. - The company has not experienced any significant changes in accounting policies or principles regarding derivative investments compared to the previous reporting period[19].